European Society for Medical Oncology

Recent papers from European Society for Medical Oncology

1. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinomaESMO Open · 2026
2. Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical societyInternational Journal of Gynecological Cancer · 2026
3. Cost-effectiveness of chemotherapy versus targeted therapy in breast cancer: A retrospective analysis in tertiary care hospitalJournal of Oncology Pharmacy Practice · 2026
4. Effect of social and digital media mental health messaging on mental health help-seeking behaviors in the sub-Saharan African population: A systematic review protocolPLoS ONE · 2026
5. ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursAnnals of Oncology · 2026
6. ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitorsESMO Open · 2026
7. The First Swiss National Nutrition Survey in Children and Adolescents, menuCH-Kids: Study Design, Participants, and Data QualitySHILAP Revista de lepidopterología · 2026
8. Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovationAnnals of the Rheumatic Diseases · 2026
9. Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real‐World DataClinical Pharmacology & Therapeutics · 2026
10. Single-molecule localization microscopy imaging of extracellular vesicle DNA in recipient cellsJournal of Translational Medicine · 2026
11. Alert on recent misleading health claim that using cosmetics makes you happier!Journal of the European Academy of Dermatology and Venereology · 2025
12. ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitorsRadiotherapy and Oncology · 2025
13. ESMO basic requirements for AI-based biomarkers in oncology (EBAI)Annals of Oncology · 2025
14. ESMO guidance on the use of Large Language Models in Clinical Practice (ELCAP)Annals of Oncology · 2025
15. Retinal Vascular Density and Vessel Diameter in Sturge–Weber Syndrome Assessed by OCT-AngiographyJournal of Clinical Medicine · 2025
16. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancerESMO Open · 2025
17. ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitorsAnnals of Oncology · 2025
18. ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapyRadiotherapy and Oncology · 2025
19. Practical cancer nutrition, from guidelines to clinical practice: a digital solution to patient-centred careESMO Open · 2025
20. Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilitiesThe Journal of Prevention of Alzheimer s Disease · 2025